SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medical Devices News
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Jedd7/7/2008 10:15:57 AM
   of 7
 
I've been watching Vicor Technologies, Inc. (VCRT). Their PD2i Cardiac Analyzer has garnered the attention of the US Army who want to use Vicor's proprietory cardiac risk assessment for Trauma and Emergency Response.
Vicor, in collaboration with the U.S. Army, will evaluate the severity of injury, and probability of survival, for critically injured combat casualties and critically ill civilian patients.
An article in Health Journal, June 24th, reports that the PD2i Cardiac Analyzer uses an algorithm that can assess a patient's risk to die from Sudden Cardiac Death (SCD) by analyzing heart beats. The PD2i has the ability of predicting SCD, with greater than 95% sensitivity and 81% specificity within a six month period. The test can be administered in a cardiologist's office in 20 minutes.
As of now the stock is low volume and current market capitalization is about $30 million. It won't take long before the real story of Vicor Technologies and the revenue potential of this stock is realized.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News